Francesco Berti | Head Of Antigen Design, Preclinical Research And Development
GlaxoSmithKline
Dr. Berti earned his bachelor in Chemistry (1998) and PhD in Chemical Science (2002) degrees at the University of Siena (Italy). In 2002 he joined GSK Vaccines (formerly Novartis Vaccines; formerly Chiron Vaccines) as a scientist and in the following 10 years he was appointed Project Leader, Laboratory/Unit/Department Head.
In April 2018 he has been appointed Scientific Director - Technical R&D, which is his current position. Dr. Berti has also served as a visiting scientist at the National Research Council (Ottawa, Canada) in 2008 and at the Genomic Institute of Novartis Foundation (La Jolla, CA, US) in 2010.
In the last 18 years, he has been working on R&D of carbohydrate- and protein-based antigens against bacterial (N. meningitidis ABCW135YX, group A and B Streptococcus, S. aureus, etc.) and viral infections (HIV, etc.). Dr. Berti has authored and co-authored of approximately 85 published scientific papers/reviews and more than 20 patents.
Appearances:
Pre-congress Workshops, April 6 @ 2:00
WORKSHOP G (CONTINUED): ANALYTICAL METHODS TO SUPPORT VACCINE QUALITY
- Molecular size, from distribution coefficient to multiple measured characteristics using light scattering-not as easy as you would think
- Use of NMR assays for characterization of polysaccharide-based vaccines
- A regulatory perspective on NGS for adventitious virus detection in biologics
- Panel with all speakers
Sign Up for Event Updates
Organiser
